The Discovery
The Mystery of the Missing Peptide
In 1988, Dr.
Key moment
Robson Santos made a surprising discovery.
In 1988, Dr. Robson Santos made a surprising discovery. He was studying brain tissue when he found Angiotensin (1-7). This seven amino acid peptide shouldn't have been there based on what scientists knew. The renin-angiotensin system was supposed to be simple: one main product called Angiotensin II. But nature had a secret. Ang(1-7) appeared in his samples like an unexpected guest. Other scientists started finding it in heart, lungs, and blood vessels too. Something important was hiding in plain sight.
The Breakthrough
Finding the Missing Piece
For years, scientists couldn't figure out what Ang(1-7) did.
Key moment
Michael Bader's team made a breakthrough.
For years, scientists couldn't figure out what Ang(1-7) did. They knew it existed but not why. Then in 2003, Dr. Michael Bader's team made a breakthrough. They found the Mas receptor—the lock that Ang(1-7) fits into perfectly. Suddenly everything changed. When Ang(1-7) attached to Mas, it turned on protective systems in the heart. It relaxed blood vessels. It reduced inflammation. It stopped harmful scarring. The piece they'd been missing wasn't trash. It was a lifeguard protecting your heart.
The Trials
The Good Guy and The Bad Guy
Think of the renin-angiotensin system as a superhero team with a traitor.
Key moment
Think of the renin-angiotensin system as a superhero team with a traitor.
Think of the renin-angiotensin system as a superhero team with a traitor. Angiotensin II is the villain. It squeezes blood vessels tight, raises pressure, causes inflammation, and scars the heart. For decades, doctors only knew to block Angiotensin II. But Ang(1-7) revealed a better strategy. Instead of just stopping the bad guy, you could power up the good guy. Ang(1-7) does everything Angiotensin II does in reverse. The two peptides fight for control of your blood vessels. Science was finally understanding the battle.
The Crisis
The COVID Connection
In 2020, the world learned about ACE2.
Key moment
It was like discovering the villain and hero were connected.
In 2020, the world learned about ACE2. The coronavirus uses this enzyme as its doorway into human cells. But ACE2 is also the factory that makes Ang(1-7). Suddenly, Ang(1-7) research exploded. Scientists asked: What if we boost Ang(1-7) to help COVID patients? What if this peptide could help lungs heal? The same enzyme that let the virus in also makes the peptide that fights inflammation. It was like discovering the villain and hero were connected. This connection turned Ang(1-7) from a curious chemical into a frontline treatment strategy.
The Legacy
The Future of Balance
Today, scientists are testing Ang(1-7) for heart failure, kidney disease, and COVID complications.
Key moment
Today, scientists are testing Ang(1-7) for heart failure, kidney disease, and COVID complications.
Today, scientists are testing Ang(1-7) for heart failure, kidney disease, and COVID complications. Early results look promising. The goal isn't to replace other treatments but to add a new tool to the medical toolbox. Instead of fighting only the bad guy, doctors now understand they should also support the good guy. Ang(1-7) represents a shift in thinking. Your body has balance built in. Sometimes healing means helping your own protection systems work better. The seven amino acids that seemed like a mystery are becoming a key to treating the hardest diseases.
Peptide history · 1988
Angiotensin II Fragment (1-7)
The blood pressure lowering peptide that changes how we treat heart disease
A seven amino acid peptide that works as nature's balance. While its cousin Angiotensin II raises blood pressure, Ang(1-7) does the opposite. Scientists discovered it works through ACE2 enzyme, the same doorway the coronavirus uses.
When this peptide was first identified
Compound classification
Current regulatory status
Main area of investigation
How this peptide is typically given
Molecular structure type
Dr. Robson Santos
Federal University of Minas Gerais, Brazil
First demonstrated Ang(1-7) in brain tissue samples
Dr. Michael Bader
Max Delbrück Center for Molecular Medicine, Berlin
Identified the Mas receptor that responds to Ang(1-7)
Dr. Schiavone
University of Foggia, Italy
Reported the first biological effects of this heptapeptide
12 milestones, 1988 – 2024.
- 1988Dr. Robson Santos discovers Ang(1-7) in brain tissue samples
- 1990Scientists find Ang(1-7) in heart and blood vessels
- 2000ACE2 enzyme identified as main producer of Ang(1-7)
- 2003Dr. Michael Bader's team identifies the Mas receptor
- 2005Research shows Ang(1-7) reduces heart scarring in animal models
- 2010Studies confirm protective effects on kidney function
- 2015First human trials begin for heart failure patients
- 2020COVID-19 pandemic sparks new research on ACE2 and Ang(1-7)
- 2021Clinical trials expand to include COVID complications
- 2022Combination studies: Ang(1-7) with standard blood pressure drugs
- 2023Research shows promise for kidney disease protection
- 2024Multiple Phase 2 trials ongoing in different disease areas
Angiotensin (1-7) works like a safety switch. Your body makes it from Angiotensin I using the ACE2 enzyme. Once created, it hunts for the Mas sensor on your heart and blood vessel cells. When it finds the Mas sensor, it turns on protective systems. These systems relax your blood vessels. They stop swelling. They prevent scarring. They reduce damage from stress. Think of it as your body's own repair crew that only shows up when the Mas alarm sounds.
Molecular structure
- Amino Acid Count
- 7 amino acids
- Molecular Weight
- 899 Daltons
- Main Source
- ACE2 enzyme
- Primary Sensor
- Mas receptor
Real stories, real lives
Maria's Story
Maria's heart wasn't pumping well. Her legs swelled. She couldn't climb stairs. After starting Ang(1-7) in a clinical trial, something shifted. Within two months, her swelling went down. Her energy returned. She could play with her grandchildren again. Her doctor explained: this peptide was helping her own heart's protection system. It wasn't fighting her body. It was joining it. For the first time in years, Maria felt like her old self. Now she volunteers to tell other patients it's worth trying.
James' Story
James took three blood pressure medicines but still struggled. His kidneys were slowly failing. Then he enrolled in an Ang(1-7) study. His blood pressure finally stabilized. More importantly, his kidney function stopped declining. His doctor showed him the numbers: less protein in his urine, better kidney markers. James realized this wasn't just another pill. It was his body finally getting the right support. His kidneys were fighting back. James now takes Ang(1-7) alongside his other medicines and has never felt better.
The future of Angiotensin (1-7)
- Heart Regeneration TherapyResearch Stage
Can Ang(1-7) help hearts heal after heart attacks? New studies show promise. The peptide helps dead heart muscle scar properly instead of failing.
- Post-COVID RecoveryResearch Stage
COVID patients with lasting lung damage might benefit. Ang(1-7) could help inflammation go down and tissues heal better.
- Kidney Disease PreventionResearch Stage
Diabetic patients often get kidney disease. Ang(1-7) might stop this before it starts by protecting kidney filters.
Be inspired
The story of Angiotensin (1-7) is ultimately about the relentless pursuit of better medicine for humanity.
Continue the legacy. The next breakthrough could be yours.